Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-pot synthesis of 3-acyl pyridines using copper/TEMPO catalysis. Offers high atom economy and mild conditions for reliable API intermediate manufacturing.
Patent CN115353511A details a safe, multi-component synthesis for carbonyl-bridged biheterocycles using in-situ CO generation, offering significant cost reduction in API manufacturing.
Patent CN112979529B reveals a novel one-step synthesis for aromatic amine indole naphthoquinone derivatives, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN118126005B reveals metal-free synthesis for high-purity pharmaceutical intermediates offering significant supply chain stability and cost advantages for global buyers.
Patent CN112480015B details a Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones, offering high yields and broad substrate scope for API manufacturing.
Patent CN111018800B reveals a mild copper-catalyzed route for N2-aryl-1,2,4-triazine derivatives, offering cost reduction in API manufacturing and scalable production.
Patent CN116813544B reveals catalyst-free heating method. Enhances supply chain reliability and cost efficiency for pharmaceutical intermediates manufacturing globally with green chemistry.
Novel radical cyclization method for high-purity phenanthridine intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN111423381A details a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN102766092A details a mild chiral spiro phosphoric acid catalyzed synthesis of optically active tetrahydroquinolines, offering high enantioselectivity and simplified purification for API manufacturing.
Patent CN116253692A reveals a metal-free route for trifluoromethyl 1,2,4-triazines. This method offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Pd-catalyzed one-pot method for 2-CF3 quinazolinones. Reduces cost in API manufacturing via safe CO sources and cheap nitro substrates.
Patent CN111978194B details a novel Pd-catalyzed carbonylation using benzyl formate. Offers cost-effective, scalable routes for pharmaceutical intermediates.
Patent CN102180755A details a green synthesis of aryl azides using cuprous oxide in water. This method offers significant cost reduction and safety advantages for pharmaceutical manufacturing.
Patent CN113980044B details a novel Ir-O-P catalyzed C-H borylation method offering high yields and broad substrate scope for pharmaceutical intermediates.
Novel palladium-catalyzed synthesis offers mild conditions and high efficiency. Enhances supply chain reliability and reduces manufacturing costs for global buyers.
Novel quinoline-substituted ligand enables high ee asymmetric trifluoromethylation. Cost-effective synthesis for pharmaceutical intermediate manufacturing supply chain.
Novel Pd-catalyzed carbonylation patent CN115286628B enables efficient synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediate manufacturing.
Novel Pd-catalyzed method for (iso)chroman amides using nitroarenes. High yield, scalable process for reliable pharmaceutical intermediate supply.
Patent CN102256981A details a novel route for Anagrelide avoiding toxic nitriles and tin waste, offering cost reduction in pharmaceutical manufacturing and high-purity intermediates.